Nanosonics (ASX:NAN), a company that develops infection control solutions, has announced the appointment of three new senior executives to further support its global expansion strategy.
Renee Salaberry has joined as chief marketing officer.
Ms Salaberry is an experienced international marketer having held senior executive roles including executive vice president and worldwide strategy director for one of the world’s largest advertising agencies, Leo Burnett, and worldwide chief strategy officer for Publicis Healthcare Communications group based in Paris and Sydney.
Most recently, she was head of marketing for Abbott Nutrition based in Sydney.
David Morris has joined as chief strategy officer and regional president Asia Pacific.
He was a member of the Cochlear executive team for over fourteen years where he held a number of executive positions including. Most recently, he was chief executive officer and managing director for Monash IVF Group.
Rod Lopez will join as chief operating officer on 4 March.
He is a highly credentialed operations professional having held senior management roles accountable for the development and execution of broad operational strategies. Mr Lopez was a senior manager at Cochlear for over 13 years, holding a number of operational roles including global head of manufacturing and chair of the Operational Excellence Strategy group.
In addition to all aspects of operations, Mr Lopez will be responsible for Nanosonics’ global service business.
“As part of our ongoing global strategic growth agenda I am delighted we have attracted such high calibre senior executives,” said CEO and president Michael Kavanagh.
“Nanosonics is at an exciting phase of its growth as we expand globally and plan for the introduction of new products. These new positions further expands the breadth and depth of experience and capability within the business and will play a pivotal role in the next phase of Nanosonics’ growth, shaping our strategic and operational agenda as we continue our global and product expansion.”